Unknown

Dataset Information

0

Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?

ABSTRACT: At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and artificial origin to combat pathogens. AMPs have several points that determine their biological activity. We analyzed the structural properties of AMPs, as well as described their mechanism of action and impact on pathogenic bacteria and viruses. Recently published data on the development of new AMP drugs based on a combination of molecular design and genetic engineering approaches are presented. In this article, we have focused on information on the amyloidogenic properties of AMP. This review examines AMP development strategies from the perspective of the current high prevalence of antibiotic-resistant bacteria, and the potential prospects and challenges of using AMPs against infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

SUBMITTER: Kurpe SR 

PROVIDER: S-EPMC7765370 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?

Kurpe Stanislav R SR   Grishin Sergei Yu SY   Surin Alexey K AK   Panfilov Alexander V AV   Slizen Mikhail V MV   Chowdhury Saikat D SD   Galzitskaya Oxana V OV  

International journal of molecular sciences 20201215 24

At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and artificial origin to combat pathogens. AMPs have several points that determine their biological activity. We analyzed the structural properties of AMPs, as well as described their mechanism of action and impact on pathogenic bacteria and viruses. Recently published data on the development of new AMP drugs based on a combination of molecular design and genetic engineering approaches are presented. In thi  ...[more]

Similar Datasets

Unknown Amyloidogenic Peptides: New Class of Antimicrobial Peptides with the Novel Mechanism of Activity.
| S-EPMC9140876 | biostudies-literature
Genomics Ab Initio Design of Amphipathic-Symmetric Peptides against SARS-CoV-2
2021-08-26 | GSE182562 | GEO
Unknown Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids.
| S-EPMC8066833 | biostudies-literature
Unknown Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.
| S-EPMC9511441 | biostudies-literature
Unknown Antiviral Peptides as Promising Therapeutics against SARS-CoV-2.
| S-EPMC7605242 | biostudies-literature
Unknown Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2
| S-SCDT-10_1038-S44319-024-00189-4 | biostudies-other
Unknown Antimicrobial Peptides With Antibiofilm Activity Against <i>Xylella fastidiosa</i>.
| S-EPMC8606745 | biostudies-literature
Unknown Design of Three Residues Peptides against SARS-CoV-2 Infection.
| S-EPMC9612326 | biostudies-literature
Unknown Potential antiviral peptides against the nucleoprotein of SARS-CoV-2.
| S-EPMC9531640 | biostudies-literature
Unknown Antimicrobial and Amyloidogenic Activity of Peptides Synthesized on the Basis of the Ribosomal S1 Protein from Thermus Thermophilus.
| S-EPMC7504387 | biostudies-literature